After Failed Lumbar Fusion: Finding Lasting Relief with Intra-Annular Fibrin Injection

Patient Overview

Mr. Arthur Bennett, a 55-year-old retired civil engineer, presented to ValorSpine with a long and complex history of chronic lower back pain. Five years prior, he underwent an L4-L5 lumbar fusion surgery to address persistent discogenic pain and instability. While the initial recovery provided a period of relative relief, new, debilitating symptoms began to emerge approximately two years post-fusion. His current condition involved severe low back pain radiating into his left buttock and thigh, with occasional numbness, significantly impacting his daily life and ability to enjoy his retirement. He was medically retired prior to his fusion and had hoped to resume some hobbies and light travel, but his renewed pain prevented him from doing so.

The Challenge

Mr. Bennett’s primary challenge was the development of adjacent segment disease (ASD), a common complication following spinal fusion. The L4-L5 fusion, by rigidifying that segment, placed increased biomechanical stress on the adjacent discs, specifically the L3-L4 level. Diagnostic imaging, including MRI, confirmed significant degeneration and an active annular tear at L3-L4, consistent with the source of his new pain. Prior to seeking treatment at ValorSpine, Mr. Bennett’s pain level consistently rated 7 out of 10 on a daily basis. He struggled with prolonged sitting, standing, and walking, found relief only when lying down, and described his condition as “worse than before the original surgery.” The thought of facing another major, invasive spinal operation, specifically a revision surgery or another fusion, filled him with dread and anxiety, as he had already experienced the extensive recovery and uncertain outcomes of his first procedure.

Previous Treatments Tried

Following the onset of his new symptoms, Mr. Bennett pursued a range of conventional treatments. His orthopedic surgeon initially recommended a course of physical therapy, which offered minimal, fleeting relief. He received multiple lumbar epidural steroid injections over a period of 18 months, each providing only temporary dampening of his pain for a few weeks before symptoms returned to baseline. Oral pain medications, including NSAIDs and muscle relaxers, provided symptomatic management but did not address the underlying structural issue. After exhausting conservative options, his previous surgeon suggested a revision surgery, potentially extending the fusion to include the L3-L4 segment, or a disc replacement, if appropriate. Mr. Bennett was hesitant to undergo another major surgery, especially given the unpredictable outcomes and potential for further complications, including the development of ASD at yet another level. He felt trapped between debilitating pain and the daunting prospect of another invasive procedure.

Our Approach

At ValorSpine, we recognize the profound impact of chronic disc pain, especially in complex cases like Mr. Bennett’s adjacent segment disease. Our philosophy centers on precise diagnosis and minimally invasive, regenerative solutions that promote the body’s natural healing mechanisms, aiming to preserve spinal mobility rather than restrict it further. After a thorough review of Mr. Bennett’s medical history, detailed physical examination, and advanced imaging (including a comprehensive MRI and diagnostic discography to confirm the L3-L4 annular tear as his pain generator), we proposed an innovative approach: intra-annular fibrin injection. This biologic disc repair treatment offered a compelling alternative to another fusion surgery. Our team explained that fibrin, a natural clotting protein, could be precisely injected into the torn annulus of the L3-L4 disc. The goal was to seal the tear, prevent the leakage of inflammatory disc material, and initiate a reparative process within the disc, thereby stabilizing the disc and alleviating his pain, all while avoiding further surgical interventions that alter spinal biomechanics.

Treatment Process

Mr. Bennett’s intra-annular fibrin injection was performed as an outpatient procedure at ValorSpine’s state-of-the-art facility. The process began with meticulous preparation, including pre-procedure instructions regarding medication and fasting. On the day of the procedure, he was made comfortable and received mild sedation to ensure relaxation, though he remained conscious and able to communicate. The procedure itself was guided by advanced fluoroscopy (real-time X-ray imaging) to ensure unparalleled precision. Our spine specialist carefully navigated a thin needle directly into the L3-L4 disc space, specifically targeting the identified annular tear. A small amount of medical-grade fibrinogen was then introduced into the tear. This fibrin acts as a biologic sealant, forming a strong, durable clot that closes the defect in the outer disc wall. This sealing action immediately prevents the irritating nucleus pulposus material from leaking out and inflaming surrounding nerves. Crucially, the fibrin also provides a scaffold for the body’s natural healing cells to migrate and begin repairing the damaged annular tissue. The entire injection process took less than an hour, and Mr. Bennett was monitored in a recovery area for a short period before being discharged home with specific post-procedure care instructions. These instructions emphasized rest, avoiding heavy lifting or twisting, and a gradual return to activity, supported by a tailored physical therapy regimen designed to optimize healing and strengthen his core.

The Results

Mr. Bennett’s journey to recovery, while requiring patience, yielded significant and life-changing improvements. In the initial weeks following the intra-annular fibrin injection, he experienced some mild, temporary discomfort at the injection site, which is a normal part of the healing process. However, by the end of the first month, he began to notice a gradual but definite reduction in his radiating leg and buttock pain. His daily pain scores, which had consistently hovered around 7/10, started to decrease steadily. At his 3-month follow-up, Mr. Bennett reported a moderate improvement, with his pain reduced by approximately 40%. The episodes of numbness in his leg had also become less frequent and less intense. Crucially, he was no longer facing the prospect of another major revision surgery, a relief that significantly improved his mental well-being. By the 6-month mark, Mr. Bennett’s improvement was more pronounced, reaching a significant 50% reduction in his overall pain, as per the typical range for this treatment. He was able to sit for longer periods without discomfort, could stand for extended durations, and had begun re-engaging in light activities he had abandoned years ago, such as gardening and short walks with his wife. The improvement in his function was tangible: he was driving again for up to an hour comfortably, enjoying social outings, and sleeping much better. At his one-year evaluation, Mr. Bennett maintained his pain reduction, reporting a consistent 3-4/10 pain level, a dramatic change from his pre-treatment suffering. He was able to travel again, albeit with careful planning, and felt a renewed sense of independence and quality of life. The biologic repair at L3-L4 had provided the stability and relief he desperately sought, validating the decision to pursue a regenerative approach over another fusion.

Key Takeaways

Mr. Bennett’s case exemplifies the profound potential of advanced biologic disc repair for patients suffering from complex spinal conditions, particularly adjacent segment disease (ASD) following previous fusions. It highlights several critical points:

1. **Targeted Diagnosis is Paramount:** A precise diagnosis of the active pain generator, even in a spine with previous surgery, is essential for successful treatment. Our comprehensive diagnostic process confirmed the L3-L4 annular tear as the root cause of Mr. Bennett’s post-fusion pain.
2. **Avoiding Repeat Fusion:** For patients with ASD, especially those with isolated symptomatic annular tears, intra-annular fibrin injection offers a compelling, minimally invasive alternative to extending a fusion. This approach preserves remaining spinal mobility and avoids the accelerated degeneration of further adjacent segments.
3. **The Power of Biologic Repair:** Fibrin disc treatment provides a method to not only seal painful annular tears but also to stimulate the body’s natural healing response within the disc itself. This stands in contrast to treatments that only manage symptoms or involve further destructive surgery.
4. **Improved Quality of Life:** While not a “cure-all,” Mr. Bennett’s experience demonstrates that significant pain reduction and improved functional capacity are realistic outcomes, allowing patients to regain activities they once thought were lost.
5. **Patience and Persistence:** The process of biologic healing takes time. Patients must commit to the recovery protocol and understand that improvements are often gradual, continuing for many months post-procedure.

Mr. Bennett’s story is a testament to the hope and lasting relief that biologic disc repair can offer when traditional surgical options are exhausted or undesirable. ValorSpine remains committed to pioneering these advanced, patient-centric treatments.

“I honestly thought I was doomed to live with pain forever, or face another surgery that I didn’t want. ValorSpine gave me my life back. I can enjoy my retirement again, and that’s priceless.”

— Arthur Bennett

If you would like to read more, we recommend this article: After Failed Lumbar Fusion: Finding Lasting Relief with Intra-Annular Fibrin Injection